Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK/PD of NNC0471-0119 in Type 1 Diabetes
NCT04655690Phase 1Completed
- Sponsor
- Novo Nordisk
- Start
- Nov 2020
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of NNC0471-0119 in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Novo Nordisk. Primary endpoint: Number of adverse events (AEs). Started Nov 2020; status: completed.
02
Drugs
NNC0471-0119
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04655690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04655690.